from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3283/sseA

LFCtreatmentdescriptionclass of inhibitor

-2.030

Amikacinug/mL Amikacintranslation

-2.105

Cap5-10ug/mL Capreomycintranslation

-2.677

Rox10-50 ug/mL Roxithromycintranslation

-0.279

SM2-5 ug/mL Streptomycintranslation

-4.035

Tet5-10 ug/mL Tetracyclinetranslation

0.145

Rif0.2-5ug/mL Rifampicintranscription

-0.781

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.173

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.923

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.234

CPZ10-50 ug/mL Chlorpromazinerespiration

0.613

Clofazimine10-13 ug/mL Clofaziminerespiration

0.407

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.725

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.079

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.502

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.552

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.740

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.566

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.700

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.699

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.116

KCN5-20 ug/mL Potassium cyaniderespiration

0.659

NaN30.2-2 mM Sodium aziderespiration

0.706

Nigericin50 uM Nigericinrespiration

0.287

TRC10-150 ug/mL Triclosanrespiration

0.349

TRZ10-25 ug/mL Thioridazinerespiration

-2.185

Valinomycin0.5-10 uM Valinomycinrespiration

0.603

ZnSO42 mM ZnSO4respiration

0.536

menadione6-10 ug/mL Menadionerespiration

0.323

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.132

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.066

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.321

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.173

NRP_1Non-replicating persistence stage 1dosRassociated

0.742

Amp0.2mg/mL AmpicillincellWall

0.024

Cephalexin20-100 ug/mL CephalexincellWall

0.207

Cerulenin0.32-5 ug/mL CerulenincellWall

0.388

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.579

EMB10-20 ug/mL EthambutolcellWall

1.017

Eta12-40 ug/mL EthionamidecellWall

0.939

INH0.2-0.4 ug/mL IsoniazidcellWall

0.584

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.134

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.230

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.474

BZA0.12 mg/mL BenzamidearomaticAmides

-0.720

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.273

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.941

H2O24 mM hydrogen peroxideDNAdamaging

-0.487

Levo10 ug/mL LevofloxacinDNAdamaging

-0.144

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.169

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.205

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.158

UVUV-irradiationDNAdamaging

-0.848

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.047

Antimycin12.5-50 ug/mL Antimycin A?

0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.638

PA_110-50 ug/mL Antitubercular compound PA-1?

0.415

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.285

PA8240.2-2 ug/mL PA-824?

-0.071

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.130

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.440

Verapamil50 uM Verapamil?

0.442

mercaptoethanol2 mM 2-Mercaptoethanol?

0.054

methoxatin10-20 ug/mL Methoxatin?